Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.8419
+0.0099 (1.19%)
Jan 22, 2026, 4:00 PM EST - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $5.89 million as of January 23, 2026. Its market cap has decreased by -74.80% in one year.
Market Cap
5.89M
Enterprise Value
-7.83M
1-Year Change
-74.80%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $5.89M, a decrease of -68.90%. That is a compound annual growth rate of -27.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 5.89M | -1.30% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.95B |
| Johnson & Johnson | 519.37B |
| AbbVie | 374.28B |
| UnitedHealth Group | 301.25B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 267.81B |
| Novo Nordisk | 261.50B |